Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$11,864,208
+$338,374 QoQ
Shares Held
46,715
-0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.95%
of 13F equity value
Holder Rank
#1,009
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Canal Capital Management, LLC holds $33,454,879 across 10 Drug Manufacturers - General names. JNJ ranks #1 (35.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
46,715 | $11,864,208 | |
| 2 | LLY |
ELI LILLY & Co
|
7,938 | $9,521,076 | |
| 3 | AMGN |
Amgen Inc
|
24,312 | $8,803,861 | |
| 4 | ABBV |
AbbVie Inc.
|
4,890 | $1,230,519 | |
| 5 | NVS |
Novartis AG
|
2,906 | $455,428 | |
| 6 | AZN |
Astrazeneca PLC
|
1,927 | $365,397 | |
| 7 | GSK |
GSK plc
|
6,800 | $356,456 | |
| 8 | NVO |
Novo Nordisk A S
|
6,524 | $312,760 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,864,208 | 46,715 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $11,525,834 | 47,152 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $10,267,410 | 49,613 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $9,322,361 | 50,277 | Shares | Sole | 2026-01-06 | |
| 2025-06-30 | $7,596,715 | 49,733 | Shares | Sole | 2025-09-19 | |
| 2025-03-31 | $7,952,028 | 47,950 | Shares | Sole | 2025-09-19 | |
| 2024-12-31 | $6,065,218 | 41,939 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,674,351 | 47,355 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $6,554,399 | 44,844 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $6,958,461 | 43,988 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $5,834,019 | 37,221 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $6,108,359 | 39,219 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $6,476,301 | 39,127 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $5,828,465 | 37,603 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $6,365,759 | 36,036 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,679,047 | 34,764 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $5,728,247 | 32,270 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $5,523,904 | 31,168 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $4,762,075 | 27,837 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $4,204,814 | 26,036 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $4,287,029 | 26,023 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $4,030,683 | 24,525 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $3,673,721 | 23,343 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $3,390,742 | 22,775 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $3,199,473 | 22,751 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $2,980,191 | 22,727 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||